Stock Quote
Martek Biosciences Corp (MATK.O) (Nasdaq)
$18.01
23 Nov 2009
-0.55%
$18.01
--
279,424
$18.50
$17.93
$31.35
$15.36
1.00
330,110
MATK.O
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Flanagan, Robert | Chairman of the Board | -- |
| Dubin, Steve | Chief Executive Officer, Director | 1,175,550 |
| Abramson, David | President | 913,091 |
Profile
Martek Biosciences Corporation (Martek) develops omega-3 docosahexaenoic acid (DHA) products. The Company produces life’sDHA, a vegetarian source of the omega-3 fatty acid DHA, for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feed, and... Full Description
Company Address
Martek Biosciences Corp
6480 Dobbin Road
Columbia MD 21045
P: +1410.7400081
F: +1410.7402985
6480 Dobbin Road
Columbia MD 21045
P: +1410.7400081
F: +1410.7402985
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Abbott Laboratories | $53.13 | -0.51 |
| BASF SE | €41.48 | 0.00 |
| GlaxoSmithKline plc | £1,268.00 | -9.50 |
| MATK.O | Industry | |
|---|---|---|
| P/E(TTM) | 15.01 | 12.80 |
| P/S(TTM) | 1.72 | 29.90 |
| ROI(TTM) | 6.55 | 2.35 |
| ROE(TTM) | 6.66 | 3.59 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | 1.22 |
| Total Revenue | $77.83M |
| Net Income | $8.93M |
| EPS | $0.27 |
